Mar 6
|
Walgreens stock rises amid $10 billion deal with Sycamore Partners to take the drugstore chain private
|
Mar 5
|
Hims Stock Claws Back After Novo Nordisk Undercuts It With A Cheaper Wegovy
|
Mar 5
|
Healthcare Stock Could Be Good 'Buy the Dip' Play
|
Mar 5
|
3 Growth Stocks Insiders Are Betting On
|
Mar 3
|
Hims & Hers Health (NYSE:HIMS) Jumps 40% After Projecting US$2.3 Billion Revenue for 2025
|
Feb 26
|
Hims & Hers Health Full Year 2024 Earnings: In Line With Expectations
|
Feb 25
|
Why IBD 50's Top Seed, Hims & Hers, Just Crashed On Its Upbeat Earnings
|
Feb 25
|
Hims & Hers tumbles 27% as investors fear uncertainty without compounded weight-loss drugs
|
Feb 25
|
Home Depot, Hims & Hers, bitcoin and crypto stocks: Market Minute
|
Feb 25
|
Hims & Hers stock collapses, may halt some weight-loss drug sales
|
Feb 25
|
Dow Jones Futures Rise: Trump Tariffs 'Going Forward;' Nvidia, Palantir Sell Off; Hims Plunges Late
|
Feb 24
|
Hims & Hers to 'treat multiple specialties,' not just weight loss
|
Feb 24
|
Hims & Hers stock tumbles despite beating Q4 revenue estimates
|
Feb 24
|
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
|
Feb 24
|
Estimating The Intrinsic Value Of Hims & Hers Health, Inc. (NYSE:HIMS)
|
Feb 21
|
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
|
Feb 21
|
Hims & Hers shares dive on end of weight loss drug shortage
|
Feb 21
|
CrowdStrike, Hims & Hers, Rivian: Market Minute
|
Feb 21
|
Hims & Hers Acquires US-based Peptide Facility
|
Feb 20
|
Apple unveils iPhone 16e, Arista reports Q4 beat: Morning Buzz
|